Relevant Clinical Trials

Update on Novel Oral Therapy for DME

Update on Novel Oral Therapy for DME

Administered systemically, ASP-440 is a selective, safe and efficacious in…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Does Aspirin Increase Risk of AMD or Disease Progression?

Does Aspirin Increase Risk of AMD or Disease Progression?

The observational AREDS2 results demonstrate an inverse relationship betwe…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Can Fluoconinole Acetonide Implants Manage Uveitis?

Can Fluoconinole Acetonide Implants Manage Uveitis?

In this analysis of the pooled data from the three fluocinolone acetonide …

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

How Safe and Effective is Ranibizumab in AMD after 7 Years?

How Safe and Effective is Ranibizumab in AMD after 7 Years?

This cohort, representing some of the earliest patients treated with intra…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

What Patients at Risk for Geographic Atrophy?

What Patients at Risk for Geographic Atrophy?

We confirm a substantial high risk of developing GA associated with early …

Expiration Date: 6/5/2015

Max Credits: 0

View Activity

Results from the Restore Extension Study of Ranibizumab for DME

Results from the Restore Extension Study of Ranibizumab for DME

The AEs reported in the interim analysis were consistent with the publishe…

Expiration Date: 6/5/2015

Max Credits: 0

View Activity

Can Ranibizumab Resolve PEDs in AMD Patients?

Can Ranibizumab Resolve PEDs in AMD Patients?

2 mg Ranibizumab for Fibrovascular Pigment Epithelial Detachments in AMD R…

Expiration Date: 9/16/2014

Max Credits: 0

View Activity